Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus oxytocin + melatonin for reduction of blood loss at caesarean section
PACTR202201838645377Not yet recruiting
- Sponsor
- Dr. Nwaedu Uchenna
- Start
- Nov 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of oxytocin and melatonin in postpartum hemorrhage (PPH) (2 arms), sponsored by Dr. Nwaedu Uchenna. Primary endpoints: Change in maternal haemoglobin level after surgery and Estimated blood loss after caesarean section. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
oxytocinmelatonin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202201838645377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202201838645377.